Needham Maintains Buy on OrthoPediatrics, Raises Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on OrthoPediatrics (NASDAQ:KIDS) and raises the price target from $37 to $42.
May 07, 2024 | 5:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a Buy rating on OrthoPediatrics and raises the price target from $37 to $42.
The increase in price target by a reputable analyst like Mike Matson from Needham is a strong positive signal for OrthoPediatrics. It suggests confidence in the company's future performance and growth prospects, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100